Clinical Trials Bot @clinicaltrialsbot@botsin.space

NCT04179721 Suspended. Reason given: COVID-19; study will resume when restrictions are lifted. https://clinicaltrials.gov/show/NCT04179721

NCT03630367 Suspended. Reason given: Unavailability of the medication https://clinicaltrials.gov/show/NCT03630367

NCT01826448 Terminated. Reason given: No activity was observed. BRAFi-naïve participants should have received triple combination treatment (including MEK inhibitor). Continuation was not justified. https://clinicaltrials.gov/show/NCT01826448

NCT03036319 Suspended. Reason given: Enrollment and interactions/interventions are temporarily paused due to COVID-19 and are expected to resume in the future. https://clinicaltrials.gov/show/NCT03036319

NCT01615042 Terminated. Reason given: Lack of enrollment https://clinicaltrials.gov/show/NCT01615042

NCT04056637 Terminated. Reason given: COVID-19 Impacted Service Delivery and Research Infrastructure https://clinicaltrials.gov/show/NCT04056637

NCT02950181 Terminated. Reason given: Concerns over standard of care and recruiting process. Investigator left UAMS, therefore study halted immediately https://clinicaltrials.gov/show/NCT02950181

NCT04404790 Suspended. Reason given: Optimization of protocol https://clinicaltrials.gov/show/NCT04404790

NCT00090480 Terminated. Reason given: Enrollment goals unable to be reached. https://clinicaltrials.gov/show/NCT00090480

NCT03395119 Suspended. Reason given: Suspended due to COVID-19 risks https://clinicaltrials.gov/show/NCT03395119

NCT02648711 Terminated. Reason given: Company decision https://clinicaltrials.gov/show/NCT02648711

NCT03341000 Terminated. Reason given: Sponsor Decision https://clinicaltrials.gov/show/NCT03341000

NCT00739609 Terminated. Reason given: Lack of enrollment. https://clinicaltrials.gov/show/NCT00739609

NCT02389985 Terminated. Reason given: Company decision https://clinicaltrials.gov/show/NCT02389985

NCT03717532 Terminated. Reason given: Inadequate/low enrollment https://clinicaltrials.gov/show/NCT03717532

NCT00614601 Terminated. Reason given: Sponsor proceeded with a phase III study for same indication. https://clinicaltrials.gov/show/NCT00614601

NCT02532517 Terminated. Reason given: No safety issues; change in innovation strategy https://clinicaltrials.gov/show/NCT02532517

NCT03235986 Terminated. Reason given: Change in the benefit-risk balance https://clinicaltrials.gov/show/NCT03235986

NCT03517995 Withdrawn. Reason given: Grant not approved https://clinicaltrials.gov/show/NCT03517995

NCT04230720 Suspended. Reason given: Temporarily paused due to COVID-19 and will resume based on guidance of public health authorities. This is not a suspension of IRB approval. https://clinicaltrials.gov/show/NCT04230720